International Journal of Computational Biology and Drug Design
- Editor in Chief
- Dr. Zhongming Zhao
- ISSN online
- ISSN print
- 6 issues per year
- CiteScore 2020 0.4
IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.
Topics covered include
- Big data analysis and tools for biological and medical data
- Drug screening, drug discovery, drug design and re-purposing
- Biomolecular dynamics, biomolecular/phylogenetic databases
- Cellular signalling/communications, cell engineering, molecular/cellular systems
- Computational epigenetics and functional genomics
- Computational approaches in virus omics and drug targets
- Machine learning, deep learning, data mining and knowledge discovery
- Metabolomics, microbiomes and lipidomics
- Modelling, simulation and optimisation of biological systems
- Non-coding RNAs and regulation
- Medical informatics and translational informatics
- Cohort discovery, EHR-based phenotyping, predictive modelling
- Proteomics, structural biology, molecular simulation and evolution
- Single cell sequencing methods and analysis
- Software, tools, databases and web servers for computational biology
The objectives of IJCBDD are to promote dialogue among researchers from multiple disciplines and the advancement of innovative biotechnology, biological, medical and pharmaceutical sciences. The journal also seeks to establish an effective communication channel between government agencies and academic and research institutions.
The audience of IJCBDD consists of scientists, researchers, medical and pharmaceutical practitioners, academics, graduate students, professionals and engineers working and interested in learning about new trends in computational biology and drug design.
IJCBDD publishes original papers, application papers, review papers, technical reports, case studies, conference reports, management reports, book reviews, notes, commentaries, and news. Special Issues devoted to important research topics and major international conferences in the fields will occasionally be published
IJCBDD is indexed in:
- Scopus (Elsevier)
- Academic OneFile (Gale)
- BIOSIS (Clarivate Analytics)
- Chemical Abstracts (CAS)
- cnpLINKer (CNPIEC)
- DBLP Computer Science Bibliography
- Embase (Elsevier)
- Expanded Academic ASAP (Gale)
- Google Scholar
- Info Trac (Gale)
- ProQuest Advanced Technologies Database with Aerospace
IJCBDD is listed in:More journal lists/directories...
Editor in Chief
- Zhao, Zhongming, University of Texas Health Science Center at Houston, USA
- Xia, Junfeng, Anhui University, China
- Chang, Jeffrey T., University of Texas Health Science Center at Houston, USA
- Altman, Russ B., Stanford University, USA
- Athey, Brian D., University of Michigan Medical School, USA
- Bajcsy, Ruzena, University of California, Berkeley, USA
- Dunker, A. Keith, Indiana University-Purdue University Indianapolis, USA
- Li, Lang, The Ohio State University, USA
- Niemierko, Andrzej, Harvard Medical School and Massachusetts General Hospital, USA
- Xu, Dong, University of Missouri, USA
Editorial Board Members
- Ancukiewicz, Marek, Harvard Medical School and Massachusetts General Hospital, USA
- Bai, Yongsheng, Indiana State University, USA
- Chen, Yu Zong, National University of Singapore, Singapore
- Ewing, Rob M., Case Western Reserve University, USA
- Feng, Hao (Harry), Case Western Reserve University, USA
- Ghosh, Joydeep, University of Texas Austin, USA
- Guo, Yan, University of New Mexico, USA
- Honavar, Vasant, Iowa State University, USA
- Jain, Vishal, Bharati Vidyapeeth's Institute of Computer Applications and Management (BVICAM), India
- Jia, Peilin, University of Texas Health Science Center at Houston, USA
- Korkin, Dmitry, University of Missouri, USA
- Li, Aimin, Xi’an University of Technology, China
- Li, Xuan, Institute of Plant Physiology and Ecology, China
- Liu, Zhandong, Baylor College of Medicine, USA
- Pan, Yi, Georgia State University, USA
- Qian, Jiang, Johns Hopkins University, USA
- Ramanathan, K., Vellore Institute of Technology, India
- Shang, Xuequn, Northwestern Polytechnical University, China
- Wan, Jun, Indiana University, USA
- Wei, Lei, Roswell Park Cancer Center, USA
- Xia, Xuhua, University of Ottawa, Canada
- Xie, Lei, City University of New York, USA
- Zhang, Chi, Indiana University, USA
- Zhang, Yongqing, Chengdu University of Information Technology, China
- Zhao, Qi, Liaoning University, China
- Zhao, Yichuan, Georgia State University, USA
- Zheng, Huiru (Jane), University of Ulster, UK
- Zhu, Michelle M., Montclair State University, USA
A few essentials for publishing in this journal
- Submitted articles should not have been previously published or be currently under consideration for publication elsewhere.
- Conference papers may only be submitted if the paper has been completely re-written (more details available here) and the author has cleared any necessary permissions with the copyright owner if it has been previously copyrighted.
- Briefs and research notes are not published in this journal.
- All our articles go through a double-blind review process.
- All authors must declare they have read and agreed to the content of the submitted article. A full statement of our Ethical Guidelines for Authors (PDF) is available.
- There are no charges for publishing with Inderscience, unless you require your article to be Open Access (OA). You can find more information on OA here.
- All articles for this journal must be submitted using our online submissions system.
- View Author guidelines.
Mathematically modelling COVID-19 in India
24 June, 2021
A mathematical analysis published in the International Journal of Computational Biology and Drug Design has revealed the impact of the spread of the COVID-19 pandemic in India on mortality rates and suggests that the death toll may ultimately be in the millions before the pandemic subsides. Physicists Bibhatsu Kuiri, Bubai Dutta, Saikat Santra, Paulomi Mandal, Khaleda Mallick, and Ardhendu Sekhar Patra of Sidho-Kanho-Birsha University in Purulia, India, have used the SEIR model as a fundamental tool to model the spread of the novel and potentially lethal coronavirus, SARS-CoV-2, which was first identified in China in late 2019 and the spread of which had reached pandemic proportions by February-March of 2020 [...]More details...
Computers search for Huntington's disease drug candidates
24 August, 2021
Huntington's disease, previously known as Huntington's chorea, is a progressive neurodegenerative disorder. It has a strong genetic component and is considered to be an inherited disease, although one in ten cases is due to an uninherited genetic mutation... Symptoms usually begin at between the ages of 20 and 50 and life expectancy depends on age of onset, but is rarely more than 20 years from the time of the appearance of initial symptoms. There are no known cures and those in the later stages of the disease require full-time care. Writing in the International Journal of Computational Biology and Drug Design, a research team from India, describes a promising new computer-based approach to the development of putative drugs that could one day offer hope a pharmaceutical intervention in Huntington's disease. Sachin Kumar of the Department of Bioinformatics, Janta Vedic College in Baraut, Baghpat, Uttar Pradesh and colleagues have looked at the two proteins responsible for the symptoms of Huntington's disease, Mutant Huntingtin protein (HTT) and HTT-interacting protein 1 (HIP-1) as potential targets for a drug-based therapy [...]More details...